A New Approach to Reactivating HIV from Latency
重新激活潜伏期艾滋病毒的新方法
基本信息
- 批准号:10212924
- 负责人:
- 金额:$ 59.96万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-08-01 至 2024-07-31
- 项目状态:已结题
- 来源:
- 关键词:Active SitesAnatomyAttenuatedBiological AssayCD4 Positive T LymphocytesCell Culture TechniquesCellsCellular AssayCoupledDataDevelopmentEvaluationFailureFeedbackGene ExpressionGene SilencingGenetic TranscriptionGenomeGoalsGrowthHIVHIV GenomeHIV InfectionsHistone Deacetylase InhibitorIn VitroInfectionInterphase CellInterruptionInterventionInvestigationLeadLentivirus VectorLymphoid TissueMeasurementMeasuresMedical HistoryMethodsMitogensPatientsProvirusesRNA VirusesSamplingShockSupplementationT-Cell ActivationT-Cell ReceptorT-LymphocyteTransactivationViralVirusantiretroviral therapybasecofactorepigenetic silencinggenome analysisimmune clearanceimprovedin vitro Assayin vivolatent infectionnovel strategiesperipheral bloodreactivation from latencysmall moleculetat Genesvector-induced
项目摘要
SUMMARY/ABSTRACT
Combination antiretroviral therapy (ART) can control but not cure HIV infection because of reservoirs,
particularly latently infected CD4 T cells, established before ART was begun, from which infection rebounds if
ART is interrupted. To achieve a functional cure or eradication of this reservoir, “shock and kill” strategies seek
to reactivate latently infected CD4+ T-cells for elimination by immune or other mechanisms, but current
methods for reactivation predicated on the concept that harbor HIV proviruses that have been transcriptionally
silenced by epigenetic or other mechanisms have proven quite inefficient in reversing latency. This proposal
describes a new approach to reactivating latently infected cells by lentivirus vector induced expression of the
HIV tat gene. Preliminary results provide evidence of extraordinary efficiency of Tat-reactivation and the
underpinnings for an in vitro latency reactivation assay with new single cell measurements of the latently
infected cell reservoir from which infection will rebound if ART is interrupted. The Specific Aims of the proposal
are to 1) further develop the Tat-reactivation assay as a faster and more accurate assay for reservoir
evaluations in peripheral blood (PB) and lymphoid tissues (LT); determine the correlations between single cell
measurements of virus producing cells, cells with intact HIV genomes and current quantitative virus growth
assays; and 2) apply the assay to assess the impact of ART in very early stage infection to limit the size of HIV
reservoirs in PB and LT. peripheral blood (PB) and lymphoid tissues (LT). The long-term goal of investigation
of Tat-reactivation is development of more effective approaches to the “shock” component of shock and kill
approaches to reducing HIV reservoirs.
总结/摘要
联合抗逆转录病毒疗法(ART)可以控制但不能治愈艾滋病毒感染,
特别是在ART开始前建立的潜伏感染的CD 4 T细胞,如果
艺术中断了。为了实现对这一储存库的功能性治愈或根除,“休克和杀死”战略寻求
重新激活潜伏感染的CD 4 + T细胞,通过免疫或其他机制消除,但目前
基于携带HIV前病毒的概念的再激活方法,
通过表观遗传或其他机制沉默的基因在逆转潜伏期方面被证明是非常低效的。这项建议
描述了一种通过慢病毒载体诱导表达
HIV达特基因。初步结果提供了证据,证明了Tat-再活化的非凡效率,
用新的单细胞测量潜伏性细胞因子的体外潜伏性再激活试验的基础
如果ART中断,感染将从感染细胞库反弹。提案的具体目标
1)进一步开发Tat-再活化测定法,作为用于储库的更快和更准确的测定法,
外周血(PB)和淋巴组织(LT)中的评价;确定单细胞之间的相关性
病毒产生细胞、具有完整HIV基因组的细胞和当前定量病毒生长的测量
检测; 2)应用该检测来评估ART在非常早期感染中的影响,以限制HIV的大小
外周血(PB)和淋巴组织(LT)中的储存库。调查的长期目标
重新激活Tat的方法是发展更有效的方法来处理休克和杀死的“休克”部分
减少艾滋病毒储存库的方法。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Initial productive and latent HIV infections originate in vivo by infection of resting T cells.
- DOI:10.1172/jci171501
- 发表时间:2023-11-15
- 期刊:
- 影响因子:15.9
- 作者:Wietgrefe, Stephen W.;Anderson, Jodi;Duan, Lijie;Southern, Peter J.;Zuck, Paul;Wu, Guoxin;Howell, Bonnie J.;Reilly, Cavan;Kroon, Eugene;Chottanapund, Suthat;Buranapraditkun, Supranee;Sacdalan, Carlo;Tulmethakaan, Nicha;Colby, Donn J.;Chomchey, Nitiya;Prueksakaew, Peeriya;Pinyakorn, Suteeraporn;Trichavaroj, Rapee;Mitchell, Julie L.;Trautmann, Lydie;Hsu, Denise;Vasan, Sandhya;Manasnayakorn, Sopark;de Souza, Mark;Tovanabutra, Sodsai;Schuetz, Alexandra;Robb, Merlin L.;Phanuphak, Nittaya;Ananworanich, Jintanat;Schacker, Timothy W.;Haase, Ashley T.
- 通讯作者:Haase, Ashley T.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ASHLEY T. HAASE其他文献
ASHLEY T. HAASE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ASHLEY T. HAASE', 18)}}的其他基金
A New Approach to Reactivating HIV from Latency
重新激活潜伏期艾滋病毒的新方法
- 批准号:
9977118 - 财政年份:2017
- 资助金额:
$ 59.96万 - 项目类别:
Vaccine Design to Concentrate Protective Antibodies at the Mucosal Border
将保护性抗体集中在粘膜边界的疫苗设计
- 批准号:
8516458 - 财政年份:2012
- 资助金额:
$ 59.96万 - 项目类别:
Vaccine Design to Concentrate Protective Antibodies at the Mucosal Border
将保护性抗体集中在粘膜边界的疫苗设计
- 批准号:
8683100 - 财政年份:2012
- 资助金额:
$ 59.96万 - 项目类别:
Vaccine Design to Concentrate Protective Antibodies at the Mucosal Border
将保护性抗体集中在粘膜边界的疫苗设计
- 批准号:
8403858 - 财政年份:2012
- 资助金额:
$ 59.96万 - 项目类别:
In Situ Hybridization and Immunohistochemistry Core
原位杂交和免疫组织化学核心
- 批准号:
8326904 - 财政年份:2011
- 资助金额:
$ 59.96万 - 项目类别:
TOPICAL MICROBICIDE AGAINST SIV AND CHLAMYDIA
针对 SIV 和衣原体的局部杀菌剂
- 批准号:
8358219 - 财政年份:2011
- 资助金额:
$ 59.96万 - 项目类别:
Impact of Extraordinarily Large Numbers of SIV-specific CD8 T Cells on Vaginal Tr
大量 SIV 特异性 CD8 T 细胞对阴道 Tr 的影响
- 批准号:
8293429 - 财政年份:2010
- 资助金额:
$ 59.96万 - 项目类别:
Microarray Studies to Discover Novel Host Defenses in SIV Infection
微阵列研究发现 SIV 感染的新型宿主防御
- 批准号:
8010734 - 财政年份:2010
- 资助金额:
$ 59.96万 - 项目类别:
Microarray Studies to Discover Novel Host Defenses in SIV Infection
微阵列研究发现 SIV 感染的新型宿主防御
- 批准号:
8069561 - 财政年份:2010
- 资助金额:
$ 59.96万 - 项目类别:
相似海外基金
Linking Epidermis and Mesophyll Signalling. Anatomy and Impact in Photosynthesis.
连接表皮和叶肉信号传导。
- 批准号:
EP/Z000882/1 - 财政年份:2024
- 资助金额:
$ 59.96万 - 项目类别:
Fellowship
Digging Deeper with AI: Canada-UK-US Partnership for Next-generation Plant Root Anatomy Segmentation
利用人工智能进行更深入的挖掘:加拿大、英国、美国合作开发下一代植物根部解剖分割
- 批准号:
BB/Y513908/1 - 财政年份:2024
- 资助金额:
$ 59.96万 - 项目类别:
Research Grant
Doctoral Dissertation Research: Social and ecological influences on brain anatomy
博士论文研究:社会和生态对大脑解剖学的影响
- 批准号:
2235348 - 财政年份:2023
- 资助金额:
$ 59.96万 - 项目类别:
Standard Grant
Simultaneous development of direct-view and video laryngoscopes based on the anatomy and physiology of the newborn
根据新生儿解剖生理同步开发直视喉镜和视频喉镜
- 批准号:
23K11917 - 财政年份:2023
- 资助金额:
$ 59.96万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Computational comparative anatomy: Translating between species in neuroscience
计算比较解剖学:神经科学中物种之间的翻译
- 批准号:
BB/X013227/1 - 财政年份:2023
- 资助金额:
$ 59.96万 - 项目类别:
Research Grant
computational models and analysis of the retinal anatomy and potentially physiology
视网膜解剖学和潜在生理学的计算模型和分析
- 批准号:
2825967 - 财政年份:2023
- 资助金额:
$ 59.96万 - 项目类别:
Studentship
Genetics of Extreme Phenotypes of OSA and Associated Upper Airway Anatomy
OSA 极端表型的遗传学及相关上呼吸道解剖学
- 批准号:
10555809 - 财政年份:2023
- 资助金额:
$ 59.96万 - 项目类别:
Development of a novel visualization, labeling, communication and tracking engine for human anatomy.
开发一种新颖的人体解剖学可视化、标签、通信和跟踪引擎。
- 批准号:
10761060 - 财政年份:2023
- 资助金额:
$ 59.96万 - 项目类别:
Understanding the functional anatomy of nociceptive spinal output neurons
了解伤害性脊髓输出神经元的功能解剖结构
- 批准号:
10751126 - 财政年份:2023
- 资助金额:
$ 59.96万 - 项目类别:
The Anatomy of Online Reviews: Evidence from the Steam Store
在线评论剖析:来自 Steam 商店的证据
- 批准号:
2872725 - 财政年份:2023
- 资助金额:
$ 59.96万 - 项目类别:
Studentship